Alibaba to pay $600 million to resolve US drug sales probe - Reuters

Alibaba and its US digital payment processor have agreed to pay 600 million dollars to resolve a federal investigation. The Justice Department probe examined whether the companies failed to prevent the sale and importation of illegal pharmaceuticals and controlled substances. To conclude the investigation into these alleged violations, Alibaba entered into a non-prosecution agreement. This settlement aims to resolve the legal issues surrounding the distribution of prohibited medical products through the company's digital platform.